4.5 Article

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders

Journal

JOURNAL OF NEUROIMMUNE PHARMACOLOGY
Volume 10, Issue 4, Pages 645-650

Publisher

SPRINGER
DOI: 10.1007/s11481-015-9639-4

Keywords

Alzheimer's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Stroke; Adaptive immunity; Regulatory T cells; Effector T cells; Innate immunity; Neuroprotection; Neurodestruction; Neurodegenerative diseases

Funding

  1. University of Nebraska Foundation
  2. Department of Defense [W81XWH11-1-0700]
  3. National Institutes of Health [R01 NS070190, P01 DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261, R01 AG043540]

Ask authors/readers for more resources

Aberrant innate and adaptive immune responses are neurodegenerative disease effectors. Disease is heralded by a generalized, but subtle immune activation orchestrated by the release of extracellular prion-like aggregated and oxidized or otherwise modified proteins. These are responsible for an inflammatory neurotoxic cascade. The perpetrators of such events include effector T cells and activated microglia. What ensues are Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis and stroke with changed frequencies of effector T cell and reduced numbers or function of regulatory lymphocytes. The control of such immune responses could lead to new therapeutic strategies and the means to effectively combat a composite of diseases that have quite limited therapeutic options.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available